Hon. Deanna Tanner Okun

Deanna Tanner Okun is the managing partner at AMS TRADE LLP. She is an international trade attorney providing legal and strategic international trade policy advice to steer companies through the intersection where innovation confronts barriers, such as intellectual property theft, unfair trade practices, and regulatory hurdles. Her practice involves all aspects of unfair trade litigation and trade remedy advocacy. Her Section 337 work includes all stages of litigation at the U.S. International Trade Commission (ITC) from pre-institution consultation to post-remedy enforcement with Customs and Border Protection. She also represents companies in Title VII antidumping and countervailing duty investigations before the ITC and the Department of Commerce. In 2017, her client secured the first negative preliminary AD/CVD determination in over seven years and her work in trade remedy proceedings on behalf of U.S. companies extends to previously rarely used trade statutes, including Section 201, 232, and 301 investigations. She works closely with contacts in the executive, judicial, and legislative branches of the government to create innovative solutions to her clients’ legal and business challenges.

During her tenure as an ITC Commissioner, Deanna was nominated to be Deputy United States Trade Representative. In 2012, she was named Outstanding Woman of the Year by the Association of Women in International Trade (WIIT). She has served on the Federal Circuit Advisory Council since 2013. In 2019, for the seventh consecutive year, Managing Intellectual Property named Deanna one of the Top 250 Women in IP. She is also on the 2021-2022 USMCA Binational Panel Roster.

When AI Helps Generate Inventions, Who Is the Inventor?

By Andrei Iancu and Rama Elluru This commentary from the CSIS-SCSP Task Force on IP in the AI Era was originally published in the Special Competitive Studies Project’s Substack on February 15, 2024. With roots in the U.S. constitution, patent rights provide an exclusive property right in new inventions like drugs,
Read More

Standard Essential Patents and European Economic Security

By Kirti Gupta and Chris Borges On April 27, 2023, the European Commission published a draft proposal on standard essential patents (SEPs) seeking to address the perceived lack of transparency and predictability in the licensing of SEPs. The commission proposes the creation of a competence center within the European Union Intellectual
Read More

Proposed Federal Use of March-in Rights Would Weaken American Innovation

By Sujai Shivakumar and Thomas Howell   The Biden administration is considering exercising something called “march-in rights” as a policy prescription to curb drug prices. But as with any prescription, there is a need to weigh efficacy against the side-effects. In this case, there is evidence that the vast majority of
Read More